Cryo-Cell Shares Outstanding 2010-2024 | CCEL

Cryo-Cell shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Cryo-Cell Shares Outstanding 2010-2024 | CCEL

Cryo-Cell shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$95.8B
Cencora (COR)$49B
DiDi Global (DIDIY)$23.3B
ICON (ICLR)$17.5B
Natera (NTRA)$16.7B
Viatris (VTRS)$15.4B
Avantor (AVTR)$14.8B
Revvity (RVTY)$14.6B
BioMerieux (BMXMF)$12.9B
CochLear (CHEOY)$12.7B
Solventum (SOLV)$12.2B
Medpace Holdings (MEDP)$11.2B
Charles River Laboratories (CRL)$11B
Doximity (DOCS)$10.8B
HealthEquity (HQY)$8.7B
Sonic Healthcare (SKHHY)$8.5B
Bausch + Lomb (BLCO)$6.9B
Life Times (LTH)$5B
Sotera Health (SHC)$4.4B
Organon (OGN)$4B
Surgery Partners (SGRY)$3.8B
BrightSpring Health Services (BTSG)$3.4B
PACS (PACS)$3.1B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.5B
Ardent Health Partners (ARDT)$2.4B
Premier (PINC)$2.3B
GeneDx Holdings (WGS)$2.1B
Ryman Healthcare (RYHTY)$2B
GoodRx Holdings (GDRX)$1.8B